OOIR: Observatory of International Research

Papers

(The median citation count of HIV Medicine is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)

Article	Citations
	158
Issue Information	94
	76
	72
Fostemsavir and ethinyl estradiol drug interaction: Clinical recommendations for co‐administration	52
Issue Information	48
HIV ‐1 viral load and reservoir size remain stable following SARS ‐ CoV	46
Disparities in HIV continuum of care in the paediatric population: A real‐life study in Brazil	44
Clinical characteristics of monkeypox virus infections among men with and without HIV: A large outbreak cohort in Germany	43
HIV testing in primary care in a low‐prevalence area of Northeast England	41
Late diagnosis of HIV infection in Warsaw: Estimating the scale of the problem and demographic trends	33
Telemedicine in HIV health care during the COVID‐19 pandemic: An implementation research study in Buenos Aires, Argentina	31
Perspectives of people with HIV and HIV clinicians on characteristics of antiretroviral treatment and HIV‐related symptoms	30
Potentially inappropriate prescriptions and potential prescription omissions in older people living with HIV	28
User‐reported outcomes of long‐acting injectable PrEP with Cabotegravir: Real‐world experience from Milan	24
Cellular and humoral response after mRNA SARS‐CoV‐2 vaccination in kidney transplant recipients living with HIV: A cross‐sectional study	23
Aetiology of fever of unknown origin in people living with HIV : A systematic review and meta‐analysis	23
	22
Predictors of discontinuing injectable cabotegravir/rilpivirine and virologic outcomes after resuming oral antiretroviral therapy	21
Subclinical atherosclerosis as detected by carotid ultrasound and associations with cardiac and HIV‐specific risk factors; the Archi‐Prevaleat project	21
Effects of transition from paediatric to adult HIV care on virological outcomes in sub‐Saharan Africa: A systematic review and meta‐analysis	20
Areas with high HIV prevalence: A spatial analysis of nationwide claims data in Germany	20
HIV cure: Are we going to make history?	19
Loneliness and social isolation in people with HIV aged ≥50 years. The No One Alone (NOA)‐GeSIDA study conducted by the GeSIDA 12021 study group	18
	18

Issue Information	18
Assessment of targeted intervention programme under the National AIDS Control Program among men who have sex with men in India	17
Issue Information	17
Issue Information	16
Effectiveness and tolerability of dolutegravir/lamivudine in virologically suppressed people with HIV at 96 weeks in a multicentre cohort	16
Influence of physical activity on endothelial function in people living with HIV	16
The value of herpes zoster prevention in people aging with HIV: A narrative review	16
Using an automated decision support tool to improve HIV prescribing: A feasibility study	16
British HIV Association guidelines on the management of opportunistic infection in people living with HIV: The clinical management of non‐tuberculous mycobacteria 2024	16
Prescribing patterns of antiretroviral treatments during pregnancy for women living with HIV in Canada 2004–2020: A surveillance study	15
Exploring implementation considerations forgeriatric‐HIVclinics: A secondary analysis from a scoping review onHIVmodels of geriatric care	15
Oral Abstracts	15
Compassionate use of long‐acting cabotegravir plus rilpivirine for people living with HIV‐1 in need of parenteral antiretroviral therapy	15
Changing prevalence and risk factors for Toxoplasma gondii seropositivity and disease in persons with HIV	15
The first AI‐based Chatbot to promote HIV self‐management: A mixed methods usability study	15
No increased risk of tuberculosis‐related immune reconstitution inflammatory syndrome with integrase inhibitor‐based antiretroviral therapy in people withHIV with profound immunosuppression	15
Efficacy and safety of dolutegravir/rilpivirine in real‐world clinical practice. GeSIDA study 1119	14
Are there additional adverse effects of testosterone use among men living with HIV?—Data from the PUSH! study	14
Dual drivers of polypharmacy in people with HIV : Quantifying the independent associations of aging and long‐term antiretroviral therapy	14
Associations between HIV infection and frailty status and its individual components: Are frailty components disproportionally affected?	14
	13
The effect of HIV and mpox co‐infection on clinical outcomes: Systematic review and meta‐analysis	13
	13
Efficacy, durability, and tolerability of dolutegravir/lamivudine and dolutegravir/rilpivirine for the treatment of HIV in a real‐world setting in Belgium	13
Exploring the cascade of mental healthcare among people with HIV experiencing depressive symptoms in the UK and Ireland: The POPPY study	13
Issue Information	12
Response to letter by Kumar et al. on “Exploring the cascade of mental health care among people with HIV experiencing depressive symptoms in the UK and Ireland: The POPPY	11
AI in medicine: No longer the future, but the present	11
Antiretroviral treatment in people living with HIV with late diagnosis initiating ART with DTG/3TC or BIC/TAF/FTC: A real‐world cohort analysis	11
Increasing HIV early diagnosis by implementing an automated screening strategy in emergency departments	11
Gender equality in leadership of HIV care cascade clinical trials: A methodological study	11
Issue Information	11
Temporal network analysis of comorbidities among people with HIV in South Carolina	10
	10
	10
“Editorial comment on: Increased incidence of diabetes in people living with HIV treated with first‐line integrase strand transfer inhibitors: A French multicentre retrospective study”	10
Access to care and impact on HIV treatment interruptions during the COVID‐19 pandemic among people living with HIV in British Columbia	10
Stigma, depression and pillbox return among adults living with HIV in rural Tanzania: A prospective cohort study	10
Viral rebound on antiretroviral therapy in France according to region of origin, sex, and HIV acquisition group. Results from the French Hospital Database on HIV (ANRS CO4	10
Long‐acting injectable cabotegravir and rilpivirine in observational cohort studies: A systematic review on virological failure, resistance and re‐suppression outcomes in virally suppressed individual	10
Predictors of poor health‐related quality of life among people living with HIV aged ≥60 years in the PISCIS cohort: Findings from the Vive+ project	9
HCV incidence in people with HIV in southwest China: A retrospective cohort study (2004–2023)	9
The role of HIV as a risk modifier for coronary endothelial function in young adults	9
	9
Association between markers of hepatitis B virus infection and risk of virological rebound in people with HIV receiving antiretroviral therapy	9
De‐simplifying antiretroviral therapy from a single‐tablet to a two‐tablet regimen: Acceptance, patient‐reported outcomes, and cost savings in a multicentre study	9
Blood pressure and metabolic outcomes after efavirenz‐ or dolutegravir‐based therapy started in acute HIV infection	9
	9
Index	9
Knowledge and HIV‐related stigma among Portuguese healthcare professionals: A cross‐sectional analysis	9

Clinical significance and management of low‐level HIV viremia in the era of integrase strand transfer inhibitors	8
Polypharmacy in HIV : Rethinking what counts and why it matters	8
Highlights from the 20th European AIDS Conference: 15–18 October 2025, Paris, France	8
Frequent hepatitis B surface antigen ( HBsAg) clearance during tenofovir therapy in persons with HIV	8
Availability and stock‐outs of paediatric antiretroviral treatment formulations at health facilities in Kenya and Uganda	8
Y181C ‐associated virologic failure during long‐acting injectable cabotegravir/Rilpivirine in a patient engaged in intensive intravenous Chemsex	8
Author Index	8
Towards inclusive HIV cure development: Identifying important and acceptable HIV cure attributes a	8
Late diagnosis of human immunodeficiency virus ( HIV ) and its associated factors in Asian countries: A systematic review	8
Pneumocystis jirovecii pneumonia–Immune reconstitution inflammatory syndrome: A review of published cases	8
Long‐acting cabotegravir and rilpivirine in people with HIV and obesity: Real‐world outcomes from the RELATIVITY	8
Examination of factors associated with mental health of people living with HIV in Kazakhstan: A cross‐sectional study based on the two‐continua model	8
Impact of the COVID ‐19 pandemic on missed opportunities for diagnosis of HIV infection:	8
An updated systematic review of HIV‐associated cryptococcal meningitis treatment strategies	8
Issue Information	8
Oral Abstracts	8
Rapid start with bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) as initial treatment in people with human immunodeficiency virus‐1 (HIV‐1): A systematic literature rev	8
Blood‐borne virus testing in emergency departments – a systematic review of seroprevalence, feasibility, acceptability and linkage to care	8
Virtual care pathways for people living with HIV: A mixed‐methods systematic review	8
Biomarkers of inflammation and coagulation predict non‐AIDS‐defining events in a prospective cohort of virologically suppressed people living with HIV	8
“Real world” efficacy of bulevirtide in HBV/HDV‐related cirrhosis including people living with HIV: Results from the compassionate use programme at INMI Spa	7
Scars are frequently found as late sequelae in individuals affected by the 2022 mpox outbreak	7
Pharmacovigilance study of INSTIs associated with weight gain and glucose/lipid metabolism adverse events based on the FDA	7
Immunostimulatory effects of Hsp70 fragments and Hsp27 in design of novel HIV‐1 vaccine formulations	7
Clinical management of detectable viraemia during CAB / RPV long‐acting therapy: Are really	7
Effectiveness of switching regimen in people living with HIV and persistent low‐level viraemia in the modern antiretroviral treatment era	7
Change in metabolic parameters after switching from triple regimens with tenofovir alafenamide to dolutegravir‐based dual therapy. Bi‐lipid study	7
Incidence and predictors of attrition from HIV treatment among adults living with HIV in high‐caseload facilities following implementation of universal test and treat strategy in	7
Supporting long‐term engagement in HIV clinical care: Learning from the COVID ‐19 pandemic	7
Cardiovascular risk knowledge stratified by predicted cardiovascular risk level among people living with HIV attending a tertiary	7
Burden of liver steatosis and liver fibrosis in a large cohort of people living with HIV	7
Frailty and frailty screening: A qualitative study to elicit perspectives of people living with HIV and their healthcare professionals	7
Immune response to ART initiation in advanced HIV infection	7
The effect of Biktarvy (B/F/ TAF ) on whole‐body insulin sensitivity, lipid and endocrine profile in healthy volunteers	7
Sex differences in cardiovascular disease and associated factors in people living with HIV : Evidence from All of Us program	7
Point‐of‐care nucleic acid testing – a step forward in controlling the HIV epidemic: A review	7
Increased incidence of diabetes in people living with HIV treated with first‐line integrase strand transfer inhibitors: A French multicentre retrospective study	7
	6
Spatial and temporal trends in HIV / AIDS burden among South Asian countries from 1990 to 2021: A	6
Assessing weight change in adolescents and young adults with perinatally acquired HIV and integrase inhibitor use	6
Issue Information	6
Multicentre service evaluation of injectable cabotegravir and rilpivirine delivery and outcomes across 12 UK clinics (SHARE LAI‐net)	6
SARS‐CoV‐2 vaccine immunogenicity for people living with HIV: A systematic review and meta‐analysis	6
Implementation of frailty screening for older people living with HIV in Brighton, UK	6
Quality of life among people living with HIV aged 50 years and over in Australia: Identifying opportunities to support better ageing	6
CROI 2024 BHIVA working group summary	6
Late diagnosis of HIV: An updated consensus definition	6
Issue Information	6
Strategies to achieve the UNAIDS 95% HIV diagnosis target in Australia: Insights from a multidisciplinary roundtable	6
A cross‐sectional comparison of the use of frailty assessment tools in older people living with HIV	6
Intergenerational sex and early sexual debut are associated with HIV infection among transgender women in Paraguay	6
Sleep deficiency among people living with human immunodeficiency virus: A growing challenge	6
Prevalence of, risk factors for, and target organ damage from metabolic syndrome among people living with HIV on ART: A cross‐sectional analysis in Chongqing, China	6
Issue Information	6
Anticholinergic medications associated with falls and frailty in people with HIV	6
‘We want it all’:ARTpreferences assessed byDesirability ofOutcomeRanking	6
Worldwide changes in HIV ‐related stigma among people living with HIV : A cross‐temporal meta‐anal	6
Sexual dysfunction care needs of gay, bisexual, and other men who have sex with men living with HIV in Montreal, Canada	6
Treatment durability, satisfaction and quality of life in virologically suppressed HIV ‐1 people switching to doravirine: Results from the French stu	6
Impact of the COVID‐19 pandemic on the HIV care continuum and associated factors in middle‐income countries: A mixed‐methods systematic review	5
Cervical intraepithelial neoplasia progression and regression among women living with HIV in Zambia	5
Real‐world efficacy of bictegravir/emtricitabine/tenofovir alafenamide regimen in patients infected with HIV‐1 sub‐subtype A6 harbouring the L74I mutation	5
	5
Lipid nanoparticles in antiretroviral therapy: A nanotechnology breakthrough for HIV/AIDS treatment	5
	5
	5
Twelve‐month effectiveness and safety of bictegravir/emtricitabine/tenofovir alafenamide in people with HIV: Real‐world insights from BICSTaR cohorts	5
Correction to ‘Abstracts of the 19th European AIDS Conference (# EACS2023 ), October 18–21, 2023,	5
What are the predictors of change in multimorbidity among people with HIV? A longitudinal observational cohort study	5
	5
Impact of HBV serological status on HIV virological efficacy of two‐drug antiretroviral regimens: A retrospective observational study on virologically suppressed people with	5
One for all, all for one: neuro‐HIV multidisciplinary platform for the assessment and management of neurocognitive complaints in people living with HIV	5
Issue Information	5
CHildren of the Cohort Study ( CHOC ): Exploring parenting desire among people living with HI	5
Optimizing statin prescriptions for people living with HIV: Evidence for improved communication and shared care between primary care and specialist HIV	5
The outcomes of anxiety and depression symptom screening in a population with HIV : Insights from an HIV	5
Sexually transmitted and blood‐borne infection risk reduction with methadone and buprenorphine/naloxone among people with prescription‐type opioid use disorder: Findings from a Canadian pragmatic rand	5
Factors associated with uptake of gynaecological care and cervical cancer screening among women in the Swiss HIV Cohort Study	5
Efficacy and safety of bictegravir/emtricitabine/tenofovir alafenamide in Black and Hispanic/Latine adults with HIV‐1 initiating first‐line therapy: 5‐year follow‐up from two phase III stud	5
Efficacy of dolutegravir + lamivudine q.d. with food in people with TB/HIV using a rifampicin‐based regimen: A retrospective observational case series	5

Trends in preterm birth in women living with HIV in Switzerland over the last three decades: A multicentric, prospective, cohort study	5
Factors influencing the quality of life and social skills of children living with HIV: A case–control study	5
Issue Information	5
Issue Information	5
Perceived disabling physical pain and suicidal ideation in aging people living with HIV cured of hepatitis C	5
Implementing the National Vaccination Plan in people with HIV in Italy	5
Low‐level HIV viraemia during antiretroviral therapy: Longitudinal patterns and predictors of viral suppression	5
Natural occurrence of drug resistance mutations to the HIV ‐1 capsid inhibitor lenacapavir	5
An overview of consent requirements for HIV and viral hepatitis B and C testing in Europe	5
Issue Information	5
Switch to a raltegravir‐based antiretroviral regimen in people with HIV and non‐alcoholic fatty liver disease: A randomized controlled trial	4
Bictegravir/emtricitabine/tenofovir alafenamide in paediatrics: Real‐life experience from a French cohort (2019–2023)	4
	4
HIV and fracture: Risk, assessment and intervention	4
Potential drug–drug interactions in males living with HIV who use drugs to treat lower urinary tract symptoms	4
	4
Issue Information	4
Molecular epidemiological analysis and investigation of antiretroviral drug resistance profile, including capsid inhibitors, among treatment‐naïve individuals with HIV	4
Cost of non‐communicable diseases in people living with HIV in the Central Denmark Region	4
Effectiveness and safety of two‐drug regimens containing an integrase inhibitor and reverse transcriptase inhibitor in a cohort of virologically suppressed people with HIV	4
Comorbidities, comedications and potential drug–drug interactions among people living with HIV in China	4
Erratum	4
	4
HIV treatment strategies across Central, Eastern and Southeastern Europe: New times, old problems	4
Issue Information	4
Major revision version 13.0 of the European AIDS Clinical Society guidelines 2025	4
	4
	4
Issue Information	4
	4
Rapid HIV pre‐exposure prophylaxis (PrEP) initiation is safe and feasible: Experience from Wroclaw All Saints cohort in Poland 2017–2021	4
The impact of accumulating immune adaptation in circulating strains of HIV ‐1	4
Asian participants' experience in phase 3/3b studies of long‐acting cabotegravir and rilpivirine: Efficacy, safety, pharmacokinetic, and virological outcomes through week 96	4
Real‐world clinical and laboratory changes after switching to two‐drug regimen in HIV ‐suppressed individuals: 48 weeks and beyond	4
BMI as a predictor of high fasting blood glucose among people living with HIV in the Asia‐Pacific region	4
Individual characteristics and time‐updated factors associated with antiretroviral treatment interruptions among people living with HIV in British Co	4
Cytomegalovirus infection among people living with HIV in Sweden: Case profiles, treatment strategies and patient outcomes at Karolinska University Hospital 2010–2020	4
Frailty in people 50 years or older living with HIV: A sex perspective	4
Hypertriglyceridaemia and gender differences in the risk of major adverse cardiovascular events in people with HIV : A single‐centre retrospective lo	4
	4
	4
PrEP for women in Europe: a systematic literature review	4
Risk factors, management, and HPV genotyping of vulvar intraepithelial neoplasia ( VIN ) in women	4
Late diagnosis of HIV in 2022: Why so little change?	4
Recognizing International Women's Day 2026	4
Efficacy and safety of dolutegravir/lamivudine in virologically suppressed female participants: week 48 data from the pooled TANGO and SALSA studies	4
Issue Information	4
Taxonomic and functional profile of the anorectal microbiota in HIV‐positive and HIV‐negative men who have sex with men, using a metagenomic approach	3
Prevalence of osteoporosis in people living with HIV and risk factors associated in the cART era	3
	3
Monitoring the HIV response for trans people in Europe and Central Asia	3
Issue Information	3
Scaling HIV self‐testing to improve health equity among cisgender gay, bisexual and other men who have sex with men, trans and gender‐diverse people	3
The recent natural history of human papillomavirus cervical infection in women living with HIV: A scoping review of meta‐analyses and systematic reviews and the construction of a hypothetic	3
People diagnosed with HIV before continuing care in England are extremely unlikely to pass on HIV	3
Patients re‐engaging with HIV care in Guatemala: Prioritizing CD4 counting and screening for histo	3
Severe ocular Mpox in person living with advanced HIV treated with extended course of tecovirimat	3
Advanced HIV disease: A review of diagnostic and prophylactic strategies	3
Issue Information	3
Network analysis to prioritize issues for intervention to improve the health‐related quality of life of people with HIV in Spain	3
	3
Oral abstracts	3
Issue Information	3
HIV pre‐exposure prophylaxis services, provision, and delivery in the European treatment network of HIV, hepatitis and global emerging infectious diseases (NEAT ID)	3
A call for health systems to monitor the health‐related quality of life of people living with HIV	3
Comprehensive geriatric assessment for people living with HIV and frailty: A mixed‐methods feasibility randomized controlled trial	3
Issue Information	3
Transitions in treatment: A systematic review and meta‐aggregation of preferences and barriers in switching from oral to long‐acting injectable antiretroviral therapy among people living with HIV	3
Real‐world experience with weight gain among pregnant women living with HIV who are using integrase inhibitors	3
Systematic screening for age‐related comorbidities: Health care optimization among persons with HIV in an outpatient setting	3
Authors' Reply to Letter to the Editor Regarding ‘Effectiveness, safety, and patient‐reported outcomes of emtricitabine/tenofovir alafenamide‐based regimens for the treatment of HIV‐1 infection: Final	3
Long‐term immune reconstitution patterns and influencing factors in people living with HIV exhibiting suboptimal immune response after 24 months of a	3
Clinical outcomes of long‐acting cabotegravir and rilpivirine in people with HIV aged 60 and older: Real‐world data from the Spanish	3
	3
Late diagnosis of HIV persists in Sweden: Differing social determinants among migrant and non‐migrant people with HIV	3
	3
Issue Information	3
Late diagnosis of HIV among Ukrainian refugees in the Czech Republic: A retrospective, observational study	3
	3
Clinically recognized sleep disorders in people living with HIV	3
Commentary on ‘Multicentre service evaluation of injectable cabotegravir and rilpivirine delivery and outcomes across 12 UK clinics (SHARE LAI‐net)’	3
Anal cancer screening in men who have sex with men living with HIV : The pilot of anal screening study ( PASS	3
EACS Abstract 2025	3
Immunological and virological response to fostemsavir in routine US clinical care: An OPERA cohort study	3
Collection of menopause data in studies of women living with HIV: A systematic literature review	3
European Guidelines on HIV and breastfeeding: “Same, same, but different” ‐ Results from a WAVE survey	3
No evidence of asymptomatic monkeypox infection in a highly sexually active MSM population in Austria	3
Issue Information	3
Strategies for strengthening same‐day ART initiation, tracing people living with HIV lost to follow‐up and viral load monitoring mechanisms in Ethiopia	3
Rate of response to initial antiretroviral therapy according to level of pre‐existing HIV‐1 drug resistance detected by next‐generation sequencing in the strategic timing of antiretroviral treatment (	3
People with HIV and healthcare workers views on screening for cognitive impairment in people with HIV: A qualitative study	3
A qualitative study of perspectives, experiences and priority outcomes for people living with HIV and frailty	3
	3
Mpox in people with HIV: A narrative review	2
Weight and mortality in people living with HIV and heart failure: Obesity paradox in the era of glucagon‐like peptide 1 (GLP‐1) receptor agonists and sodium‐glucose cotransporter	2